炎症性肠病中肠易激综合征样症状的患病率 - Suppr | 超能文献

Prevalence of IBS-type symptoms in IBD.

作者信息

Strid Hans

机构信息

Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.

出版信息

Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1029-1031. doi: 10.1016/S2468-1253(20)30291-0. Epub 2020 Oct 2.

DOI:10.1016/S2468-1253(20)30291-0

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Prevalence of IBS-type symptoms in IBD.炎症性肠病中肠易激综合征样症状的患病率

Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1029-1031. doi: 10.1016/S2468-1253(20)30291-0. Epub 2020 Oct 2.

2

The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.儿童炎症性肠病中肠易激综合征样症状的流行情况，及其与疾病活动的生化标志物的关系。

Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25.

3

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.炎症性肠病中符合肠易激综合征标准的症状患病率：系统评价和荟萃分析。

Am J Gastroenterol. 2012 Oct;107(10):1474-82. doi: 10.1038/ajg.2012.260. Epub 2012 Aug 28.

4

Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.炎症性肠病-肠易激综合征在CCFA合作伙伴中对患者报告结局的患病率及影响

Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.

5

The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.炎症性肠病缓解期患者中肠易激综合征型症状的患病率。

Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1086-1090. doi: 10.1097/MEG.0000000000000921.

6

How can IBD be distinguished from IBS?炎症性肠病如何与肠易激综合征相区分？

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S152-4. doi: 10.1002/ibd.20696.

7

The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?曼尼托巴炎症性肠病队列研究：诊断前的长期症状——肠易激综合征占多少比例？

Clin Gastroenterol Hepatol. 2006 May;4(5):614-20. doi: 10.1016/j.cgh.2006.03.003. Epub 2006 Apr 17.

8

The overlap between IBS and IBD: what is it and what does it mean?肠易激综合征和炎症性肠病的重叠：是什么及意味着什么？

Expert Rev Gastroenterol Hepatol. 2014 Feb;8(2):139-45. doi: 10.1586/17474124.2014.876361.

9

Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.肠易激综合征和炎症性肠病的地理分布比较不能支持共同的进化根源：肠易激综合征和炎症性肠病在进化上没有关系。

Med Hypotheses. 2018 Jan;110:31-37. doi: 10.1016/j.mehy.2017.10.020. Epub 2017 Nov 2.

10

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.采用罗马IV标准评估非活动性炎症性肠病患者中肠易激综合征样症状的患病率及其与生活质量的关系。

Medicine (Baltimore). 2020 May;99(19):e20067. doi: 10.1097/MD.0000000000020067.

引用本文的文献

1

Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD).炎症性肠病（IBD）患者的精神和身心状况的四年随访。

BMC Psychol. 2024 Apr 17;12(1):211. doi: 10.1186/s40359-024-01726-5.

2

Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.色氨酸代谢“枢纽”基因表达与 COVID-19 感染和炎症性肠病中的炎症增加和严重疾病结局相关。

Int J Mol Sci. 2022 Nov 26;23(23):14776. doi: 10.3390/ijms232314776.